MENU
+Compare
MESO
Stock ticker: NASDAQ
AS OF
Jan 23, 03:47 PM (EDT)
Price
$17.97
Change
+$0.39 (+2.22%)
Capitalization
1.99B

MESO Mesoblast Limited Forecast, Technical & Fundamental Analysis

a company, which engages in the development and commercialization of biological products

Industry Biotechnology
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MESO with price predictions
Jan 08, 2025

Aroon Indicator for MESO shows an upward move is likely

MESO's Aroon Indicator triggered a bullish signal on December 31, 2024. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 136 similar instances where the Aroon Indicator showed a similar pattern. In of the 136 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The 10-day RSI Indicator for MESO moved out of overbought territory on January 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where MESO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MESO as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MESO turned negative on January 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MESO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MESO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MESO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.232) is normal, around the industry mean (15.076). P/E Ratio (0.000) is within average values for comparable stocks, (88.202). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.833). MESO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (140.845) is also within normal values, averaging (264.879).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MESO is expected to report earnings to rise 29.23% to -17 cents per share on February 28

Mesoblast Limited MESO Stock Earnings Reports
Q4'23
Est.
$-0.17
Q3'23
Missed
by $0.01
Q2'23
Beat
by $0.28
Q1'23
Beat
by $0.14
Q4'22
Beat
by $0.02
The last earnings report on November 22 showed earnings per share of -13 cents, missing the estimate of -12 cents. With 66.83K shares outstanding, the current market capitalization sits at 1.99B.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of biological products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGRX57.170.30
+0.53%
MFS Core Equity I
HDIVX15.940.05
+0.31%
Janus Henderson Responsible Intl Div I
ARIFX11.30N/A
N/A
Aristotle International Eq I
MXVHX6.80N/A
N/A
Empower Large Cap Value Instl
RYECX198.37-3.27
-1.62%
Rydex Energy C

MESO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been closely correlated with SAGE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MESO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-2.55%
SAGE - MESO
66%
Closely correlated
+1.01%
QTTB - MESO
50%
Loosely correlated
+1.18%
VTGN - MESO
48%
Loosely correlated
-0.66%
TNGX - MESO
33%
Poorly correlated
N/A
TSVT - MESO
32%
Poorly correlated
+2.86%
More